IBDEI108 ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16338,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16338,1,3,0)
 ;;=3^Neurogenic Bladder Dysfunction,Unspec
 ;;^UTILITY(U,$J,358.3,16338,1,4,0)
 ;;=4^N31.9
 ;;^UTILITY(U,$J,358.3,16338,2)
 ;;=^5015648
 ;;^UTILITY(U,$J,358.3,16339,0)
 ;;=N31.1^^61^772^80
 ;;^UTILITY(U,$J,358.3,16339,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16339,1,3,0)
 ;;=3^Neuropathic Bladder,Reflex NEC
 ;;^UTILITY(U,$J,358.3,16339,1,4,0)
 ;;=4^N31.1
 ;;^UTILITY(U,$J,358.3,16339,2)
 ;;=^5015645
 ;;^UTILITY(U,$J,358.3,16340,0)
 ;;=N32.89^^61^772^7
 ;;^UTILITY(U,$J,358.3,16340,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16340,1,3,0)
 ;;=3^Bladder Disorders,Other Spec
 ;;^UTILITY(U,$J,358.3,16340,1,4,0)
 ;;=4^N32.89
 ;;^UTILITY(U,$J,358.3,16340,2)
 ;;=^87989
 ;;^UTILITY(U,$J,358.3,16341,0)
 ;;=N33.^^61^772^6
 ;;^UTILITY(U,$J,358.3,16341,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16341,1,3,0)
 ;;=3^Bladder Disorders,Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,16341,1,4,0)
 ;;=4^N33.
 ;;^UTILITY(U,$J,358.3,16341,2)
 ;;=^5015654
 ;;^UTILITY(U,$J,358.3,16342,0)
 ;;=N34.2^^61^772^115
 ;;^UTILITY(U,$J,358.3,16342,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16342,1,3,0)
 ;;=3^Urethritis
 ;;^UTILITY(U,$J,358.3,16342,1,4,0)
 ;;=4^N34.2
 ;;^UTILITY(U,$J,358.3,16342,2)
 ;;=^88231
 ;;^UTILITY(U,$J,358.3,16343,0)
 ;;=N34.1^^61^772^116
 ;;^UTILITY(U,$J,358.3,16343,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16343,1,3,0)
 ;;=3^Urethritis,Nonspec
 ;;^UTILITY(U,$J,358.3,16343,1,4,0)
 ;;=4^N34.1
 ;;^UTILITY(U,$J,358.3,16343,2)
 ;;=^5015655
 ;;^UTILITY(U,$J,358.3,16344,0)
 ;;=N39.0^^61^772^120
 ;;^UTILITY(U,$J,358.3,16344,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16344,1,3,0)
 ;;=3^Urinary Tract Infection,Site Not Spec
 ;;^UTILITY(U,$J,358.3,16344,1,4,0)
 ;;=4^N39.0
 ;;^UTILITY(U,$J,358.3,16344,2)
 ;;=^124436
 ;;^UTILITY(U,$J,358.3,16345,0)
 ;;=N31.0^^61^772^81
 ;;^UTILITY(U,$J,358.3,16345,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16345,1,3,0)
 ;;=3^Neuropathic Bladder,Uninhibited NEC
 ;;^UTILITY(U,$J,358.3,16345,1,4,0)
 ;;=4^N31.0
 ;;^UTILITY(U,$J,358.3,16345,2)
 ;;=^5015644
 ;;^UTILITY(U,$J,358.3,16346,0)
 ;;=R31.9^^61^772^60
 ;;^UTILITY(U,$J,358.3,16346,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16346,1,3,0)
 ;;=3^Hematuria,Unspec
 ;;^UTILITY(U,$J,358.3,16346,1,4,0)
 ;;=4^R31.9
 ;;^UTILITY(U,$J,358.3,16346,2)
 ;;=^5019328
 ;;^UTILITY(U,$J,358.3,16347,0)
 ;;=R31.0^^61^772^57
 ;;^UTILITY(U,$J,358.3,16347,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16347,1,3,0)
 ;;=3^Hematuria,Gross
 ;;^UTILITY(U,$J,358.3,16347,1,4,0)
 ;;=4^R31.0
 ;;^UTILITY(U,$J,358.3,16347,2)
 ;;=^5019325
 ;;^UTILITY(U,$J,358.3,16348,0)
 ;;=R31.1^^61^772^56
 ;;^UTILITY(U,$J,358.3,16348,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16348,1,3,0)
 ;;=3^Hematuria,Benign Essential Microscopic
 ;;^UTILITY(U,$J,358.3,16348,1,4,0)
 ;;=4^R31.1
 ;;^UTILITY(U,$J,358.3,16348,2)
 ;;=^5019326
 ;;^UTILITY(U,$J,358.3,16349,0)
 ;;=N40.0^^61^772^3
 ;;^UTILITY(U,$J,358.3,16349,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16349,1,3,0)
 ;;=3^BPH w/o Lower Urinary Tract Symptoms
 ;;^UTILITY(U,$J,358.3,16349,1,4,0)
 ;;=4^N40.0
 ;;^UTILITY(U,$J,358.3,16349,2)
 ;;=^5015689
 ;;^UTILITY(U,$J,358.3,16350,0)
 ;;=N40.1^^61^772^2
 ;;^UTILITY(U,$J,358.3,16350,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16350,1,3,0)
 ;;=3^BPH w/ Lower Urinary Tract Symptoms
 ;;^UTILITY(U,$J,358.3,16350,1,4,0)
 ;;=4^N40.1
